If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

The Diabetes Research Group at Aston University studies the regulation of nutrient metabolism, the pathogenesis of diabetes mellitus and obesity, and the development of new therapies. Specific interests include:

  • Pathogenesis and interventional approaches against insulin resistance
  • Discovery and development of agents to treat diabetes and obesity
  • Islet transplantation and therapeutic use of genetically modified insulin-releasing cells
  • Study design and evaluation of therapies for diabetes and obesity

Teaching Activity

I contribute to lectures and practical classes in physiology and lectures and workshops in clinical pharmacy.

Employment

Professor and Head of Diabetes Research, Aston University
Formerly Reader and Senior Lecturer in Pharmacology, and Lecturer in Physiology, Aston University

1998 FRCP, Fellowship, Royal College of Physicians, Edinburgh
1996 FRCPath, Fellowship, Royal College of Pathologists

Membership of Professional Bodies

  • British Endocrine Society
  • British Pharmacological Society
  • Diabetes UK, Medical and Scientific Section
  • European Association for the Study of Diabetes
  • Founding member of EASD Islet Study Group
  • International Society of Diabetes & Vascular Disease
  • Royal College of Pathologists
  • Royal College of Physicians, Edinburg

Administrative Roles

Director Biomedical Sciences Research - Nutritional Biomedicine Research Group

Member of the Pharmacy and Biology Teaching Programmes

Member of research strand 'Mechanisms of age-related transitions' - Aston Research Centre for Healthy Ageing

Member of research strand: 'Technologies supporting healthy ageing' -  Aston Research Centre for Healthy Ageing

Awards

1995      Ciba Lecture prize in Clinical Biochemistry
1996     Citations in Who’s Who in Science (USA), Who’s Who in Medicine (USA)
2001      Howard Kolodny Lecture, Albert Einstein College of Medicine, New York
2003      St. Andrew’s Symposium Lecture, Royal College of Physicians, Edinburgh
2007      University of Bath, Pharmacy Centenary Lecture
2008      Fernandez-Cruz XXVII Memorial Symposium Lecturer
2012      American Diabetes Association, State-of-the-Art Lecturer
2013      The Lunar Society Medal
2014      Elsie Bertram Memorial Lecture, University of East Anglia
2015      Banting Memorial Lecturer 2015
2015      Royal Society of Biology Charter Lecturer
2016      Aston University Anniversary Chair

Contact Details

Email: c.j.bailey@aston.ac.uk 
telephone: +44 (0) 121 204 3898
fax: +44 (0) 121 204 3892

Fingerprint Dive into the research topics where Clifford Bailey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Type 2 Diabetes Mellitus Medicine & Life Sciences
Metformin Medicine & Life Sciences
Insulin Medicine & Life Sciences
Glucose Medicine & Life Sciences
Hypoglycemic Agents Medicine & Life Sciences
Insulin Resistance Medicine & Life Sciences
rosiglitazone Medicine & Life Sciences
Medical problems Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

Bailey, C. J., Del Prato, S., Wei, C., Reyner, D. & Saraiva, G., 1 Nov 2019, In : Diabetes, Obesity and Metabolism. 21, 11, p. 2564-2569 6 p.

Research output: Contribution to journalArticle

Open Access
File
Type 2 Diabetes Mellitus
Metformin
saxagliptin
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
Placebos

FDA guidance on cardiovascular risk of antidiabetic therapies: one decade later

Bailey, C. J., 1 May 2019, In : Diabetes, Obesity and Metabolism. 21, 5, p. 1079-1080 2 p.

Research output: Contribution to journalComment/debate

rosiglitazone
Hypoglycemic Agents
Industry
Head
Safety

GIP analogues and the treatment of obesity-diabetes

Bailey, C. J., 19 Nov 2019, In : Peptides.

Research output: Contribution to journalArticle

Gastric Inhibitory Polypeptide
Medical problems
Obesity
Type 2 Diabetes Mellitus
Therapeutics

Insulin resistance: Impact on therapeutic developments in diabetes

Bailey, C. J., 23 Apr 2019, In : Diabetes and Vascular Disease Research. 16, 2, p. 128-132 5 p.

Research output: Contribution to journalReview article

Open Access
File
Insulin Resistance
Therapeutics
Thiazolidinediones
Metformin
Hyperinsulinism

Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes

Lascar, N., Altaf, Q-A., Raymond, N. T., Brown, J. E., Pattison, H., Barnett, A., Bailey, C. J. & Bellary, S., 2 Nov 2019, In : Current Medical Research and Opinion. 35, 11, p. 1893-1900 8 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Young Adult
Diabetes Complications
Ovarian Diseases
Exercise

Thesis

Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology

Author: Iyire, A., 7 Nov 2016

Supervisor: Mohammed, A. (Supervisor) & Bailey, C. J. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Fatty acids, monocytes and ageing

Author: Pararasa, C., 22 Nov 2013

Supervisor: Griffiths, H. R. (Supervisor) & Bailey, C. J. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Improving the function of islet and beta-cell grafts

Author: Paget, M. B., Dec 2008

Supervisor: Bailey, C. J. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Insulin gene therapy for the treatment of diabetes mellitus

Author: Stewart, C., Mar 1993

Supervisor: Bailey, C. J. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File

Interventions against obesity through increased lipolysis in adipose tissue

Author: Richardson, D. K., Sep 2002

Supervisor: Bailey, C. J. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Philosophy

File